What We're Reading: Page 150
Industry reads hand-picked by our editors
Sep 20, 2021
Sep 17, 2021
-
Endpoints News
The biggest questions facing gene therapy, the XLMTM community, and Astellas after fourth patient death
-
Evaluate Vantage
Biogen leads the amyotrophic lateral sclerosis hopefuls
-
STAT
New study revives a Mozart sonata as a potential epilepsy therapy
-
Reuters
China's biotech sector comes of age with big licensing deals, global ambitions
Sep 16, 2021
-
The Washington Post
At the besieged FDA, ‘it never stops!’ as decisions loom on boosters, pediatric shots and more
-
Business Insider
How China quietly grew into a biotech powerhouse that will shape the future of the drug industry
-
The New York Times
Democrats’ Stumble on Drug Prices Shows Power of Industry
-
Kaiser Health News
How Fauci and the NIH Got Ahead of the FDA and CDC in Backing Boosters
Sep 15, 2021
-
Bloomberg Government
Drug Pricing Opponents Complicate Democrats' Health Ambitions
-
Nature
The tangled history of mRNA vaccines
-
FierceBiotech
Sanofi dumps Principia Biopharma's San Francisco labs with plans to immediately cut 38 jobs
-
Evaluate Vantage
Front-line competition lines up behind Keytruda
Sep 14, 2021
-
Evaluate Vantage
Esmo 2021 – Mirati bids to be belle of the ball
-
The Wall Street Journal
After Covid-19 Data Is Deleted, NIH Reviews How Its Gene Archive Is Handled
-
C&EN
A sizzling biotech job market is streamlining the course to a career in chemistry
-
Reuters
WHO-backed vaccine hub for Africa to copy Moderna COVID-19 shot
Sep 13, 2021
-
BioCentury
Fred Frank, co-founder of the biotech industry, is dead at 89
-
Reuters
Britain begins world's largest trial of blood test for 50 types of cancer
-
STAT
A vaccine veteran steps away from the NIH, looking out toward the world
-
FiercePharma
Bausch pays whopping $300M to settle Glumetza pay-for-delay lawsuit after 800% price hike
Sep 10, 2021
-
Associated Press
Sweeping new vaccine mandates for 100 million Americans
-
The Wall Street Journal
Theranos Trial Paused Over Possible Juror Covid-19 Exposure
-
The Economist
Why scientists are deliberately infecting volunteers with Covid-19
-
Endpoints News
Martin Shkreli to go toe-to-toe with new FTC chair over Daraprim price spikes
Previous
